about
Perturbed desmosomal cadherin expression in grainy head-like 1-null miceAndrogenetic alopecia: new insights into the pathogenesis and mechanism of hair lossMale Androgenetic AlopeciaAndrogenetic alopecia in men aged 40-69 years: prevalence and risk factorsThe proteomic profile of hair damage.Epidermal Wnt/β-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factorsReview: spironolactone may be effective for hirsutism but data are lacking on its effectiveness for acne vulgaris in women.Validating the use of Medicare Australia billing data to examine trends in skin cancerA gene for pili annulati maps to the telomeric region of chromosome 12q.Long-term clearance of patch-stage mycosis fungoides with the 308-nm laser.Hirsutism: from Brazil to a place near you.Understanding and managing common baldness.Diffuse hair loss.Bioprospecting keratinous materials.Male pattern androgenetic alopecia.Fungal nail infection: diagnosis and management.Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study.Getting ahead of head lice.Genetics of alopecia areata.Beyond goosebumps: does the arrector pili muscle have a role in hair loss?Nail apparatus melanoma.Androgenetic alopecia in men and women.Hirsuties.Management of male pattern hair loss.Review of management of purpura fulminans and two case reports.Disorders of hair in infants and children other than alopecia.Successful treatment of perianal Bowen's disease with imiquimod.Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.Morphological approach to hair disorders.Androgenetic alopecia: pathogenesis and potential for therapy.Immunological aspects of pregnancy.Miniaturized Hairs Maintain Contact with the Arrector Pili Muscle in Alopecia Areata but not in Androgenetic Alopecia: A Model for Reversible Miniaturization and Potential for Hair Regrowth.Treatment of monilethrix with oral minoxidil.Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.An estimation of the prevalence of nonmelanoma skin cancer in the U.S.Management of primary cicatricial alopecias: options for treatment.Male pattern baldness: current treatments, future prospects.Primary cicatricial alopecia: diagnosis and treatment.How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia.A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation.
P50
Q24315989-05C1A380-997F-4EDF-8E50-6DB998BAC087Q26784610-6DA5F160-4D50-43C0-99AC-899E223004F3Q28085012-F66AFF4D-1D91-457A-8737-4E9B0EF882CCQ28191418-EE0A7CB7-A583-4396-9534-848DC1E1B5FDQ30417625-FE1AEFAE-38B6-4956-B5C9-5A395174D897Q30576465-A0277D28-6A41-4819-AF5C-1CB8170B87DAQ30927837-2D4EACD5-C368-4D5B-BFBF-B75673997F0EQ31052024-5E7D357D-492D-43AF-B2C5-4AA0D064D528Q33210215-FBABCBE8-C5F7-46DE-92F2-71610F2BAC9DQ33265101-8EC91FCF-C7F8-475E-A435-B1B0FC512F93Q33525337-C4327480-00A0-45CD-A3F6-D19113598E15Q33546842-3012EDDA-C2B2-41B7-995E-06A0272C77B6Q33659265-5322F9E6-BFB1-4B6F-9F81-0BE030E5197DQ33781182-E6939FED-E321-4F39-B3C0-4596EAFFBA50Q33792005-E9713192-A7AA-4160-88C9-2032FF577B2BQ34040292-B9A7E909-CA06-41C3-B3D5-870168868B4EQ34059662-BAB5CAB1-C368-4130-B822-548AD87D2EA7Q34097895-ED2ADBBE-62D4-4066-9A5A-97555F0E8491Q34097902-A9388F30-F9B2-4541-8819-8ED0CC2D54FCQ34153311-F3B40000-362C-4262-BE9E-93BEC21F80F5Q34222653-148AE4BE-BCCC-439A-B3D3-8D3D2AE77924Q34276914-2FDD494B-911D-4821-9785-184B7D159EE8Q34276927-3618169A-3901-479A-BF3D-FC35B5A5EBDEQ34323321-0E9CEC6B-A037-4178-890F-DA8D8E712053Q34382413-F4F793BD-72BC-4240-8380-D54676F35602Q34534791-67A0CE71-A013-42A4-9FBC-44971CAC43DBQ34577079-726BE2BD-9005-48B2-A66B-5E118DB1A03AQ34620072-774DCA22-D566-4851-832E-555CC6E58DD8Q35190548-95AB2330-4563-4232-B295-8FBECC61D553Q35571130-47DA6CA4-522E-48DD-B0D1-7440A6B3E737Q36400342-95144982-82FD-4789-ABBC-82A1AFC1E8EAQ36405000-AC0DFD95-6FB5-40A8-BB60-43686192B635Q36952905-1FA37E29-8058-4945-8F68-5DD929F222FEQ37114851-243C5003-8605-4D8E-9D5D-2F1F0207B7BEQ37119162-2102EC98-C4DE-40CD-9880-40CDC9D16BDAQ37167668-CD93E563-F7AF-4ADC-9906-7189F7E37292Q37212419-B5EF1F3E-876B-48A7-A1B8-DDAED7B1EA2DQ37373202-A790FEAD-C896-4F38-8995-7D1534919AD1Q37381748-CECB8B82-2606-413D-9CA9-9041CCF2C912Q37677874-287F597F-59FA-4A0E-B9D7-2DD77E2D522F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rodney Sinclair
@ast
Rodney Sinclair
@en
Rodney Sinclair
@es
Rodney Sinclair
@nl
Rodney Sinclair
@sl
Родни Синклер
@ru
type
label
Rodney Sinclair
@ast
Rodney Sinclair
@en
Rodney Sinclair
@es
Rodney Sinclair
@nl
Rodney Sinclair
@sl
Родни Синклер
@ru
prefLabel
Rodney Sinclair
@ast
Rodney Sinclair
@en
Rodney Sinclair
@es
Rodney Sinclair
@nl
Rodney Sinclair
@sl
Родни Синклер
@ru
P106
P1153
55504165900
P21
P2456
P31
P3835
rodney-sinclair
P496
0000-0001-6751-1428